Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Pilots should not use Alka-Seltzer Plus before or during flight operations, particularly the nighttime formulations and “Non-Drowsy” day products that contain dextromethorphan (DXM), a cough suppressant that impairs cognitive function and coordination. Under Federal Aviation Regulation 91.17, pilots are prohibited from acting as crew members while using any drug that affects their faculties “in any way contrary to safety,” and Alka-Seltzer Plus—even its over-the-counter variants—clearly violates this standard. A pilot operating a commercial or private aircraft while medicated with Alka-Seltzer Plus doesn’t just risk their own life; they endanger every passenger and person on the ground. The stakes are not theoretical.
Accidents involving drug impairment—whether over-the-counter, prescription, or illicit—are fatal more than 90% of the time. This statistic reflects a harsh reality: when a pilot’s judgment, reaction time, and motor control are compromised by medication, there is almost no room for recovery from an emergency. Alka-Seltzer Plus is widely available, often taken without much thought, and frequently misrepresented as safe for pilots. It is not.
Table of Contents
- What Active Ingredients in Alka-Seltzer Plus Are Problematic for Pilots?
- How Does Alka-Seltzer Plus Affect Pilot Cognition and Safety?
- What Does the FAA Say About Over-the-Counter Cold Medications for Pilots?
- Why Is There a Difference Between Alka-Seltzer Plus Day and Night Formulations, and Does It Matter for Pilots?
- What Does Recent Legal Action Reveal About Alka-Seltzer Plus and Drowsiness Claims?
- Why Should Pilots Treat Even Over-the-Counter Medications Seriously?
- What Should Pilots Do Instead of Taking Alka-Seltzer Plus?
- Conclusion
What Active Ingredients in Alka-Seltzer Plus Are Problematic for Pilots?
alka-Seltzer Plus products contain several active ingredients, but two are particularly problematic for aviation. The most concerning is dextromethorphan hydrobromide (DXM), a cough suppressant found in both Day and Night formulations. The Night formulations add doxylamine succinate, a sedating antihistamine, along with acetaminophen and phenylephrine hydrochloride. These ingredients work synergistically to affect the central nervous system in ways that directly compromise a pilot’s ability to fly safely.
Dextromethorphan is classified as a “DNF” (Do Not Fly) medication when present in any formulation, whether labeled as day or night. This classification exists because DXM causes drowsiness, dizziness, and impaired cognitive function—even at recommended doses. Doxylamine, found in the night formulations, is one of the most sedating antihistamines available over-the-counter, causing significant drowsiness that can last for hours or even into the next day. A pilot who takes an Alka-Seltzer Plus night product in the evening may still be impaired the following morning. This is not a minor side effect; it directly affects the prefrontal cortex, the brain region responsible for decision-making, risk assessment, and complex motor coordination—the exact skills a pilot must rely on in the cockpit.
How Does Alka-Seltzer Plus Affect Pilot Cognition and Safety?
The medications in Alka-Seltzer Plus depress the central nervous system in measurable ways. Dextromethorphan, even at therapeutic doses, reduces alertness, increases reaction time, and impairs visual tracking—abilities that are essential for instrument flying and managing unexpected situations. Doxylamine, used in nighttime products, is substantially more sedating, often causing drowsiness that persists well into the next day. For a pilot, this means reduced ability to scan instruments, delayed responses to warnings, and compromised judgment in weather or emergency situations.
The impairment is not always obvious to the person experiencing it. A pilot who feels “mostly okay” after taking Alka-Seltzer Plus may have measurably slower reaction times and reduced visual acuity without realizing it. This false sense of capability is particularly dangerous because it can lead to overconfidence in the cockpit. The FAA’s regulations recognize this risk, which is why any medication affecting “faculties in any way contrary to safety” is prohibited. The key word is “any way”—there is no threshold of “minor impairment” that becomes acceptable in aviation.
What Does the FAA Say About Over-the-Counter Cold Medications for Pilots?
The FAA does not maintain a simple “black list” of banned medications, but instead classifies medications based on their safety profile. For many cold and flu remedies, the classification is “NO GO,” meaning pilots must wait at least 5 dosage intervals after the last dose before flying. For DXM-containing products like Alka-Seltzer Plus, the restriction is stricter: these are “DNF” (Do Not Fly) medications with no flying permitted while taking them or for a set period after the last dose. Federal Aviation Regulation 91.17 explicitly states that no person shall act as a crew member of an aircraft if that person is using any drug that affects their faculties “in any way contrary to safety.” This is not limited to prescription medications.
Over-the-counter drugs are included. The regulation places the burden on the pilot: it is the pilot’s responsibility to know what they’re taking, understand its effects, and ensure those effects don’t compromise flight safety. A pilot cannot claim ignorance of a medication’s side effects as a defense for flying while impaired. If a pilot chooses to fly while taking Alka-Seltzer Plus, they are knowingly violating federal aviation regulations and putting themselves and others at serious risk.
Why Is There a Difference Between Alka-Seltzer Plus Day and Night Formulations, and Does It Matter for Pilots?
Alka-Seltzer Plus markets “Day” products as “Non-Drowsy” and “Night” products as formulations designed to help with sleep. The difference is the addition of doxylamine in the night products. However, this distinction offers little comfort to pilots because both formulations contain dextromethorphan, the core problematic ingredient. The day formulations claim to be “Non-Drowsy,” but dextromethorphan is associated with drowsiness regardless of what else is in the product. In fact, a class action lawsuit filed in federal court alleges that Bayer, the manufacturer, has been marketing Alka-Seltzer Plus “Day” products as Non-Drowsy even though they contain dextromethorphan, which has drowsiness as a documented side effect. The products named in the lawsuit include Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy Citrus, Alka-Seltzer Plus Cold & Flu PowerMAX Gels Day Non-Drowsy, and Alka-Seltzer Plus Maximum Strength Cold & Flu Day Non-Drowsy Liquid Gels.
The night formulations are unquestionably worse for pilots because of the added doxylamine, but the day formulations are not safe either. A pilot might reason that if they take only a day formulation, they’re minimizing risk. This reasoning is flawed and dangerous. Both products contain DXM, both carry aviation safety risks, and neither should be used by anyone planning to fly. The marketing distinction between day and night products is designed for consumer convenience, not aviation safety. Pilots must view all Alka-Seltzer Plus products as off-limits, regardless of the label.
What Does Recent Legal Action Reveal About Alka-Seltzer Plus and Drowsiness Claims?
In June, a class action lawsuit was filed in U.S. District Court for the District of New Jersey against the manufacturer of Alka-Seltzer Plus, alleging that the company markets these products as “Non-Drowsy” despite containing dextromethorphan, which has drowsiness as a documented side effect. The court recently partially denied the manufacturer’s motion to dismiss the suit, allowing the case to proceed. This legal development is significant for pilots because it confirms what aviation safety experts have long maintained: the “Non-Drowsy” claim on these products is misleading and inaccurate.
The lawsuit essentially acknowledges that consumers, including pilots, may be purchasing these products based on false or misleading advertising about their drowsiness effects. If a manufacturer is being sued for falsely advertising a product as “Non-Drowsy” when it actually causes drowsiness, that should raise immediate red flags for any pilot considering using it. The fact that a court found the allegations credible enough to let the case proceed indicates that the distinction between the claimed and actual effects is substantial. This is a cautionary tale: a pilot who sees “Non-Drowsy” on the label and assumes the product is safe for flying is operating under false assumptions that a court is now examining.
Why Should Pilots Treat Even Over-the-Counter Medications Seriously?
Many pilots underestimate the risks of over-the-counter medications because they’re readily available and don’t require a prescription. This complacency is dangerous. The FAA’s regulations don’t distinguish between prescription and over-the-counter drugs—both are evaluated on their safety profile for flying. The fact that a medication can be purchased at any drugstore does not make it safe for the cockpit. In fact, the widespread availability of cold and flu medications like Alka-Seltzer Plus may contribute to a false sense of safety. A pilot might think, “This is just a common cold medicine; how bad can it be?” The answer is: very bad, especially in aviation.
Consider a scenario: a pilot wakes up with cold symptoms before a scheduled flight. They take Alka-Seltzer Plus to manage congestion and cough, expecting it to help them feel well enough to fly. The medication begins to take effect, and the pilot feels slightly better. But the DXM and doxylamine are simultaneously impairing their cognition and reaction time. The pilot takes off, feeling capable and in control, unaware that their abilities are measurably reduced. Now, if weather deteriorates, an instrument malfunctions, or another aircraft enters their airspace unexpectedly, the pilot’s impaired state could be the difference between a safe recovery and a catastrophic accident.
What Should Pilots Do Instead of Taking Alka-Seltzer Plus?
The FAA’s guidance is clear: if an illness is serious enough to require medication, it is serious enough to prevent you from flying. This is not a suggestion; it is a safety principle grounded in decades of accident investigation data. A pilot who is sick enough to need Alka-Seltzer Plus or any similar cold medication should stay on the ground. This protects not only the pilot but also everyone who depends on that pilot to make sound decisions and maintain aircraft safely. If a pilot is ill and considering whether to fly, the proper course of action is to consult with their designated Aviation Medical Examiner (AME) or contact the FAA Regional Flight Surgeon before using any over-the-counter medications.
These medical professionals can evaluate the pilot’s condition and provide guidance specific to their situation. In most cases, the answer will be to rest, recover, and reschedule the flight. The few hours or days saved by flying while sick are never worth the safety risks. Pilots should also remember that the FAA has enforcement authority and can investigate accidents thoroughly, including toxicology. A pilot who flies while impaired by Alka-Seltzer Plus and causes an accident will face not only legal liability but also regulatory action and potential certificate revocation.
Conclusion
Pilots must understand that Alka-Seltzer Plus, despite being an over-the-counter medication available at every drugstore, is incompatible with flight operations. The dextromethorphan and doxylamine in these products impair the exact cognitive and motor functions that safe flying requires. The FAA’s regulations prohibit flying while using any drug that affects faculties “in any way contrary to safety,” and Alka-Seltzer Plus clearly meets that threshold. The recent legal action against the manufacturer further confirms that the “Non-Drowsy” claims on these products are misleading and that drowsiness and cognitive impairment are real, documented effects.
The decision to fly while sick and medicated is not a personal choice that affects only the pilot; it affects everyone in the aircraft and on the ground. The 90% fatality rate for accidents involving drug-impaired pilots underscores the gravity of this issue. The safest course of action is always to remain grounded when ill, consult with an AME or FAA Regional Flight Surgeon before using any medications, and remember that the few hours or days delayed by not flying are a small price for safety. A pilot’s license is a privilege, not a right, and it comes with the responsibility to prioritize safety above convenience.
